Insulin-Like Growth Factor I in Human Thyroid Tissue: Specific Localization by Immunohistochemistry and In Situ Hybridization
- PMID: 12114741
- DOI: 10.1007/BF02739884
Insulin-Like Growth Factor I in Human Thyroid Tissue: Specific Localization by Immunohistochemistry and In Situ Hybridization
Abstract
Insulin-like growth factor I and II (IGF-l and IGF-ll) have been implicated in the replication of normal thyroid follicular cells in vitro. This study evaluates the distribution and abundance of immunoreactive IGF-l by histochemical analysis in human thyroid tissue with different histopathologic characteristics. We used two types of highly specific and sensitive polyclonal rabbit anti-IGF-l antibodies and one monoclonal antibody (MAb) with the immunoperoxidase technique on sections of 25 glands harboring adenomatous goiter; 11 glands with follicular adenoma (FA); 45 glands with thyroid carcinoma of papillary, follicular, and undifferentiated types; and 18 glands with Graves' disease. Immunoreactive IGF-l was present in some thyroid follicular cells of all thyroid tissues examined. The percentage of cells staining positively varies among the different processes, being lowest in normal thyroid tissues and highest in all thyroid carcinomas. The cytoplasmic pattern of IGF-l immunoreactivity also varied among the different thyroid conditions. Furthermore, using nonradioactive in situ hybridization (ISH) we detected IGF-l mRNA in the thyroid cells of adenomatous goiter. The expression was higher in the histologically hyperplastic areas. These findings provide further support for an autocrine and/or paracrine role of IGF-l in the function and/or growth of normal thyroid follicular cells and suggest that IGF-l may play a role in the dysfunctional growth of thyroid follicular cells in adenomatous goiter, thyroid carcinoma, and Graves' hyperthyroidism.
Similar articles
-
Expression of vascular endothelial growth factor and presence of angiovascular cells in tissues from different thyroid disorders.World J Surg. 2010 Feb;34(2):242-8. doi: 10.1007/s00268-009-0344-4. World J Surg. 2010. PMID: 20041248
-
Insulin-like growth factor-1 and insulin-like growth factor receptor in thyroid tissues of patients with Graves' disease.Int J Mol Med. 1998 Oct;2(4):483-6. doi: 10.3892/ijmm.2.4.483. Int J Mol Med. 1998. PMID: 9857239
-
Expression of fibroblast growth factor-2 and fibroblast growth factor receptor-1 in thyroid diseases: difference between neoplasms and hyperplastic lesions.Endocr J. 1998 Feb;45(1):35-43. doi: 10.1507/endocrj.45.35. Endocr J. 1998. PMID: 9625444
-
Altered expression of insulin-like growth factor-I (IGF-I) and IGF binding proteins during rat thyroid hyperplasia and involution.Growth Factors. 1994;10(3):207-22. doi: 10.3109/08977199409000239. Growth Factors. 1994. PMID: 7524574
-
Thyroid transcription factor-1 in normal, hyperplastic, and neoplastic follicular thyroid cells examined by immunohistochemistry and nonradioactive in situ hybridization.Mod Pathol. 2000 May;13(5):570-6. doi: 10.1038/modpathol.3880098. Mod Pathol. 2000. PMID: 10824930
Cited by
-
The role of insulin-like growth factor 1 in the development of benign and malignant thyroid nodules.Balkan Med J. 2012 Jun;29(2):133-8. doi: 10.5152/balkanmedj.2011.034. Epub 2012 Jun 1. Balkan Med J. 2012. PMID: 25206982 Free PMC article.
-
Immunodetection of Insulin-Like Growth Factor I (IGF-l) in Normal and Pathological Adrenocortical Tissue.Endocr Pathol. 1998 Spring;9(1):63-70. doi: 10.1007/BF02739953. Endocr Pathol. 1998. PMID: 12114663
-
The role of insulin-like growth factor I-II receptor on development of pleomorphic adenoma.Eur Arch Otorhinolaryngol. 2017 Sep;274(9):3443-3447. doi: 10.1007/s00405-017-4644-2. Epub 2017 Jun 17. Eur Arch Otorhinolaryngol. 2017. PMID: 28625007